UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa

Rheumatology (Oxford, England), 2009-12, Vol.48 (12), p.1560-1565

2009

Volltextzugriff (PDF)

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

Journal of the American Society of Nephrology, 2007-07, Vol.18 (7), p.2180-2188

2007

Volltextzugriff (PDF)

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials

Annals of the rheumatic diseases, 2015-01, Vol.74 (1), p.177-184

2015

Volltextzugriff (PDF)

Long-term patient survival in ANCA-associated vasculitis

Annals of the rheumatic diseases, 2011-03, Vol.70 (3), p.488-494

2011

Volltextzugriff (PDF)

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

The New England journal of medicine, 2010-07, Vol.363 (3), p.211-220

2010

Volltextzugriff (PDF)

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.955-960

2012

Volltextzugriff (PDF)

Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.1003-1010

2013

Volltextzugriff (PDF)

Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (7), p.1655-1665

2023

Volltextzugriff (PDF)

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse

PloS one, 2016-12, Vol.11 (12), p.e0165402-e0165402

2016

Volltextzugriff (PDF)

Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse

Arthritis research & therapy, 2017-06, Vol.19 (1), p.129-129, Article 129

2017

Volltextzugriff (PDF)

Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome

Rheumatology (Oxford, England), 2019-01, Vol.58 (1), p.103-109

2019

Volltextzugriff (PDF)

Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan

Journal of rheumatology, 2014-02, Vol.41 (2), p.325

2014

Volltextzugriff (PDF)

High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement

Journal of the American Society of Nephrology, 2003-11, Vol.14 (11), p.2926-2933

2003

Volltextzugriff (PDF)

A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.2030-2037

2012

Volltextzugriff (PDF)

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts

Rheumatic & musculoskeletal diseases open, 2017-01, Vol.3 (1), p.e000449-e000449

2017

Volltextzugriff (PDF)

2710 The importance of monitoring creatinine, hematuria, and proteinuria in relation to kidney outcomes in patients with ANCA-associated vasculitis

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

Det första steget för ett svenskt njurbytesprogram

Läkartidningen, 2019-06, Vol.116

Westman, Kerstin

2019

Volltextzugriff (PDF)

The European Vasculitis Society 2016 Meeting Report

Kidney international reports, 2017-11, Vol.2 (6), p.1018-1031

2017

Volltextzugriff (PDF)

The long-term outcomes of systemic vasculitis

Nephrology, dialysis, transplantation, 2015-04, Vol.30 Suppl 1 (Jan 18), p.i60-i66

2015

Volltextzugriff (PDF)

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

Arthritis and rheumatism, 2012-02, Vol.64 (2), p.542-548

2012

Volltextzugriff (PDF)

2201 Assessment of long-term cardiovascular comorbidities in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

The Swedish Society of Nephrology: Microscopic hematuria - no useless finding

Läkartidningen, 2016-05, Vol.113

Westman, Kerstin

2016

Volltextzugriff (PDF)

FC058: Long-Term Renal Survival of Anca-Associated Vasculitis Patients Included in the Euvas Randomized Clinical Trials

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Volltextzugriff (PDF)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1178-1182

2015

Volltextzugriff (PDF)

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials

Rheumatology (Oxford, England), 2015-03, Vol.54 (3), p.471-481

2015

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(18)
Schwedisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials

Long-term patient survival in ANCA-associated vasculitis

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis

Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse

Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse

Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome

Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan

High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement

A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts

2710 The importance of monitoring creatinine, hematuria, and proteinuria in relation to kidney outcomes in patients with ANCA-associated vasculitis

Det första steget för ett svenskt njurbytesprogram

The European Vasculitis Society 2016 Meeting Report

The long-term outcomes of systemic vasculitis

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

2201 Assessment of long-term cardiovascular comorbidities in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

The Swedish Society of Nephrology: Microscopic hematuria - no useless finding

FC058: Long-Term Renal Survival of Anca-Associated Vasculitis Patients Included in the Euvas Randomized Clinical Trials

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials

Suchergebnisse filtern